You are here: Home / Sites / University of Colorado Health Science Center / HIrsch, Fred R.

HIrsch, Fred R. (M.D., Ph.D.)

Staff, University of Colorado Health Science Center, 303-724-3858

Contact Information


To update contact information, please visit the Data Management and Coordinating Center.

Open Protocols

None Available.

Closed Protocols

No closed protocols.


Publication Name PubMed ID Journal
Chromosomal aneusomy in bronchial high-grade lesions is associated with invasive lung cancer. 17989344 Am. J. Respir. Crit. Care Med.
Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group Study S0126. 16622257 J. Clin. Oncol.
The bronchioloalveolar carcinoma and peripheral adenocarcinoma spectrum of diseases. 17409882 J Thorac Oncol
Biological markers for non-small cell lung cancer patient selection for epidermal growth factor receptor tyrosine kinase inhibitor therapy. 16778092 Clin. Cancer Res.
Spectral karyotyping detects chromosome damage in bronchial cells of smokers and patients with cancer. 17600274 Am. J. Respir. Crit. Care Med.
Promoter characterization of Semaphorin SEMA3F, a tumor suppressor gene. 16005989 Biochim. Biophys. Acta
Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines. 16424029 Cancer Res.
Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model. 16314486 Am. J. Pathol.
Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines. 16877703 Mol. Cancer Res.
High prevalence of occult endobronchial malignancy in high risk patients with moderate sputum atypia. 16022912 Lung Cancer
Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer. 16609045 Clin. Cancer Res.
HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients. 16288303 Br. J. Cancer
Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib. 16600976 Ann. Oncol.
Multi-target interphase fluorescence in situ hybridization assay increases sensitivity of sputum cytology as a predictor of lung cancer. 15350627 Cancer Detect. Prev.
Bronchioloalveolar carcinoma: a model for investigating the biology of epidermal growth factor receptor inhibition. 15217959 Clin. Cancer Res.
Prognostic significance of occult tumor cells in the apheresis products of patients with advanced breast cancer receiving high-dose chemotherapy and autologous hematopoietic progenitor cell support. 15148495 Biol. Blood Marrow Transplant.
High prevalence of endobronchial malignancy in high-risk patients with moderate dysplasia in sputum. 15136448 Chest
Chemoprevention of lung cancer--from biology to clinical reality. 14760107 Ann. Oncol.
Recent developments in biomarkers for the early detection of lung cancer: perspectives based on publications 2003 to present. 15220746 Curr Opin Pulm Med
Comparative analysis of algorithms for signal quantitation from oligonucleotide microarrays. 14751998 Bioinformatics
Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer. 16707605 Clin. Cancer Res.
A major lung cancer susceptibility locus maps to chromosome 6q23-25. 15272417 Am. J. Hum. Genet.
EU-USA pathology panel for uniform diagnosis in randomised controlled trials for HRCT screening in lung cancer. 16899486 Eur. Respir. J.
RAGE in lung tumors. 17200506 Am. J. Respir. Crit. Care Med.
Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. 15886315 J. Clin. Oncol.
Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels. 17145836 Clin. Cancer Res.
Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients. 16051952 J. Clin. Oncol.
Proteomic patterns of preinvasive bronchial lesions. 16179643 Am. J. Respir. Crit. Care Med.
Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer. 15870435 J. Natl. Cancer Inst.
Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study. 15998906 J. Clin. Oncol.
Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. 12953099 J. Clin. Oncol.
Premalignant evolution of lung cancer: Gilles F Filley lecture. 15136432 Chest
Sputum cytological atypia as a predictor of incident lung cancer in a cohort of heavy smokers with airflow obstruction. 14578133 Cancer Epidemiol. Biomarkers Prev.
Nuclear accumulation of beta-catenin occurs commonly in the epithelial cells of juvenile polyps. 15557107 Pediatr. Res.
Pulmonary prostacyclin synthase overexpression chemoprevents tobacco smoke lung carcinogenesis in mice. 15313935 Cancer Res.
Molecular classification and molecular genetics of human lung cancers. 14981576 Semin. Oncol.
Overexpression of vascular endothelial growth factor and its receptors in bronchial dypslasia demonstrated by quantitative RT-PCR analysis. 15777969 Lung Cancer
Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer. 17075123 J. Clin. Oncol.
Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapy. 17082511 Ann. Oncol.
Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib. 17317677 Ann. Oncol.
Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. 16540689 Cancer Res.
Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum. 17406356 Br. J. Cancer
EGFR-mutant lung adenocarcinoma in a patient with Li-Fraumeni syndrome. 17540308 Lancet Oncol.

To update protocols, publications, biomarkers, or science data, please contact the Informatics Center.


Mail Stop F8104, P.O. Box 6511
University of Colorado

To update addresses, please visit the Data Management and Coordinating Center.

🔜 Data-Sci Workshop
The EDRN Biomarker Data Science Workshop is coming this August, 2020. More details available soon.
Announcement 03/17/2020

The EDRN Registration page will be available soon to register for the 35th EDRN Steering Committee Meeting, now scheduled to take place from June 30-July 2, 2020, in Tempe, AZ.

This icon signifies that something is happening and we kindly ask you to please wait